# Contact and animal-care questions

> Contact and reporting | Peptide for Paws — Contact information at Peptide for Paws: where animal-care and adverse-reaction questions go, and the limits of this editorial research site.

An editorial page cannot assess a pet. A veterinarian can put a paper beside the animal’s actual condition.

## Questions about a pet

Questions about symptoms, a proposed medicine or a suspected reaction go to the pet’s veterinarian. Choosing a medicine or reviewing an animal’s case requires care beyond an editorial site. The [FDA’s animal-drug questions](https://www.fda.gov/animal-veterinary/safety-health/frequently-asked-questions-about-animal-drugs) explains the veterinary role in prescribing and in reports about drug problems.

This site has no clinical intake, submission form or monitored reader inbox. Leaving that limit plain matters to me: a pet-care question needs to reach someone able to act on it.

## Reporting an animal-drug problem

The [FDA’s reporting page for animal-drug side effects and product problems](https://www.fda.gov/animal-veterinary/report-problem/how-report-animal-drug-and-device-side-effects-and-product-problems) explains the reporting options for approved, indexed and unapproved products, including compounded medicines. It is the contact source for that purpose; discussing an experience on an editorial site does not file a report.

For a question about a claim on these pages, the [reading list](/references) identifies the underlying publications and guidance. A useful correction would identify the page address, the exact sentence and the source that changes it. I’m still bothered by the missing copper-peptide identity in the [paw-pad case](/paw-pads).

---

At Peptide for Paws I follow published veterinary research back to the animal on the ground; these essays offer no medical advice, and a pet’s medicine belongs with its veterinarian.